meglumine and Cancer of Prostate

meglumine has been researched along with Cancer of Prostate in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (9.68)18.2507
2000's2 (6.45)29.6817
2010's24 (77.42)24.3611
2020's2 (6.45)2.80

Authors

AuthorsStudies
Antic, T; Chatterjee, A; Fan, X; Karczmar, GS; Oto, A; Pittman, JM; Yousuf, A1
Ahn, H; Hong, JH; Jeong, IG; Kim, CS; Kim, H; Kim, JK; Kim, M; Kim, MH; Pak, S; Park, KJ; Song, C; You, D1
Andersen, MH; Borre, M; Elkjær, MC; Høyer, S; Pedersen, BG1
Antic, T; Chatterjee, A; Fan, X; He, D; Karczmar, GS; Mathew, M; Oto, A; Pineda, F; Szasz, T; Wang, S; Yousuf, A1
Elfatairy, KK; Filson, CP; Geller, RL; Nour, SG; Osunkoya, AO; Sanda, MG1
Jeong, H; Kim, YA; Lee, MS; Moon, MH; Son, H; Sung, CK; Woo, H1
Balestreri, L; Girometti, R; Pancot, M; Signor, MA; Urbani, M; Zuiani, C1
Eward, W; Gupta, RT; Lavien, G; Peterson, AC; Said, N; Sexton, SJ1
Barentsz, JO; Hambrock, T; Huisman, HJ; Hulsbergen-van de Kaa, CA; Kobus, T; Litjens, GJ; Scheenen, TW; Vos, EK1
Razzak, M1
Aigner, F; Bektic, J; Jaschke, W; Junker, D; Kobel, C; Kremser, C; Schäfer, G1
Bratan, F; Lartizien, C; Mège-Lechevallier, F; Niaf, E; Rabilloud, M; Roche, L; Rouvière, O1
Barentsz, JO; Bock, M; Fütterer, JJ; Krafft, AJ; Maier, F; Schlemmer, HP; Schouten, MG; Zamecnik, P1
Alberich-Bayarri, Á; Ferrer, A; García-Martí, G; Martí-Bonmatí, L; Pérez, R; Prats-Montalbán, JM; Sanz-Requena, R1
Fan, X; Karczmar, GS; Medved, M; Oto, A; Pineda, FD; Wang, S; Yousuf, A1
Bazzocchi, M; Fongione, S; Girometti, R; Pancot, M; Pullini, S; Signor, MA; Zuiani, C1
Barentsz, JO; Fütterer, JJ; Hambrock, T; Hoeks, C; Yakar, D1
Ben Cheikh, A; Chapelon, JY; Gelet, A; Girouin, N; Glas, L; Lyonnet, D; Mège-Lechevallier, F; Rabilloud, M; Rouvière, O1
Barentsz, JO; Fütterer, JJ; Hambrock, T; Hoeks, CM; Huisman, H; Hulsbergen-van de Kaa, CA; van Lin, E; van Oort, IM; Vergunst, H; Witjes, JA; Yakar, D1
Ingrisch, M; Müller-Lisse, UG; Müller-Lisse, UL; Reiser, MF; Scherr, MK; Seitz, M1
Elman, B; Jonca, F; Leandri, P; Malavaud, B; Mouly, P; Portalez, D; Rollin, G1
Chapelon, JY; Dantony, E; Gelet, A; Girouin, N; Glas, L; Lyonnet, D; Mège-Lechevallier, F; Rabilloud, M; Rouvière, O1
Autorino, R; Buonerba, C; Caraglia, M; De Sio, M; Di Lorenzo, G; Ferro, M; Fusco, R; Perdonà, S; Petrillo, A; Ronza, FM; Setola, SV1
Fuller, DB; Low, RN; Muradyan, N1
Cheon, J; Cho, SB; Kim, MJ; Kim, YH; Lee, SA; Park, BJ; Sung, DJ; Whang, SY1
Bassi, PF; Bonomo, L; Cina, A; Gui, B; Pierconti, F; Pinto, F; Totaro, A; Valentini, AL1
Battisti, S; Beomonte Zobel, B; Cazzato, RL; D'Agostino, F; Del Vescovo, R; Faiella, E; Giulianelli, R; Giurazza, F; Grasso, RF; Pisanti, F; Quattrocchi, CC; Russo, V; Setola, R1
Bonanno, E; Carlani, M; Finazzi Agrò, E; Mancino, S; Simonetti, G1
Demlow, TA; Franzini, DA; Hanna, RM; Kim, J; Quinn, SF; Rosencrantz, DR; Szumowski, J1
Brown, JJ; Heiken, JP; Mirowitz, SA1
Barentsz, JO; de la Rosette, JJ; Jager, GJ; Oosterhof, GO; Ruijs, SH; Ruijter, ET; Thornbury, JR; van de Kaa, CA1

Trials

2 trial(s) available for meglumine and Cancer of Prostate

ArticleYear
Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues.
    Magnetic resonance imaging, 2016, Volume: 34, Issue:2

    Topics: Adult; Aged; Computer Simulation; Contrast Media; Dose-Response Relationship, Drug; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neovascularization, Pathologic; Organometallic Compounds; Prostatic Neoplasms; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spin Labels

2016
Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI.
    European radiology, 2010, Volume: 20, Issue:1

    Topics: Aged; Contrast Media; High-Intensity Focused Ultrasound Ablation; Humans; Male; Meglumine; Neoplasm Recurrence, Local; Organometallic Compounds; Prognosis; Prostatic Neoplasms; Rectum; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

2010

Other Studies

29 other study(ies) available for meglumine and Cancer of Prostate

ArticleYear
Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer.
    Academic radiology, 2022, Volume: 29, Issue:6

    Topics: Contrast Media; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prostatic Neoplasms; Reproducibility of Results

2022
Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?
    Clinical genitourinary cancer, 2020, Volume: 18, Issue:1

    Topics: Aged; Biopsy, Large-Core Needle; Contrast Media; Diffusion Magnetic Resonance Imaging; Humans; Image-Guided Biopsy; Male; Meglumine; Middle Aged; Multiparametric Magnetic Resonance Imaging; Neoplasm Grading; Neoplasm Staging; Organometallic Compounds; Predictive Value of Tests; Prognosis; Prostate; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Risk Assessment; Ultrasonography, Interventional; Watchful Waiting

2020
Prostate cancer: in-bore magnetic resonance guided biopsies at active surveillance inclusion improve selection of patients for active treatment.
    Acta radiologica (Stockholm, Sweden : 1987), 2018, Volume: 59, Issue:5

    Topics: Aged; Contrast Media; Denmark; Humans; Image-Guided Biopsy; Magnetic Resonance Imaging, Interventional; Male; Meglumine; Middle Aged; Organometallic Compounds; Patient Selection; Prospective Studies; Prostatic Neoplasms

2018
Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer.
    Academic radiology, 2018, Volume: 25, Issue:3

    Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Humans; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostatectomy; Prostatic Neoplasms; ROC Curve

2018
In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability study.
    The British journal of radiology, 2018, Volume: 91, Issue:1084

    Topics: Aged; Conscious Sedation; Contrast Media; Humans; Image Interpretation, Computer-Assisted; Image-Guided Biopsy; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pilot Projects; Prostatic Neoplasms; Reproducibility of Results; Retreatment; Retrospective Studies

2018
Is Prostate Imaging Reporting and Data System Version 2 Sufficiently Discovering Clinically Significant Prostate Cancer? Per-Lesion Radiology-Pathology Correlation Study.
    AJR. American journal of roentgenology, 2018, Volume: 211, Issue:1

    Topics: Aged; Contrast Media; Diagnostic Errors; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Predictive Value of Tests; Prostatectomy; Prostatic Neoplasms; Retrospective Studies

2018
Multiparametric magnetic resonance imaging versus Partin tables and the Memorial Sloan-Kettering cancer center nomogram in risk stratification of patients with prostate cancer referred to external beam radiation therapy.
    La Radiologia medica, 2018, Volume: 123, Issue:10

    Topics: Aged; Aged, 80 and over; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nomograms; Organometallic Compounds; Organs at Risk; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment

2018
Magnetic resonance imaging features of pubic symphysis urinary fistula with pubic bone osteomyelitis in the treated prostate cancer patient.
    Abdominal radiology (New York), 2019, Volume: 44, Issue:4

    Topics: Aged; Contrast Media; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Osteomyelitis; Prostatic Neoplasms; Pubic Bone; Pubic Symphysis; Urinary Fistula

2019
Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
    European urology, 2013, Volume: 64, Issue:3

    Topics: Area Under Curve; Contrast Media; Humans; Magnetic Resonance Imaging; Male; Meglumine; Neoplasm Grading; Organometallic Compounds; Predictive Value of Tests; Prognosis; Prostatectomy; Prostatic Neoplasms; Reproducibility of Results; Retrospective Studies; ROC Curve

2013
Prostate cancer: aggressiveness--MRI can tell.
    Nature reviews. Urology, 2013, Volume: 10, Issue:8

    Topics: Contrast Media; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prostatic Neoplasms

2013
Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis.
    AJR. American journal of roentgenology, 2014, Volume: 202, Issue:3

    Topics: Aged; Algorithms; Computer Systems; Contrast Media; Elasticity Imaging Techniques; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multimodal Imaging; Organometallic Compounds; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity

2014
Prostate focal peripheral zone lesions: characterization at multiparametric MR imaging--influence of a computer-aided diagnosis system.
    Radiology, 2014, Volume: 271, Issue:3

    Topics: Aged; Area Under Curve; Contrast Media; Diagnosis, Computer-Assisted; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Preoperative Period; Prospective Studies; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; ROC Curve

2014
Automated real-time needle-guide tracking for fast 3-T MR-guided transrectal prostate biopsy: a feasibility study.
    Radiology, 2014, Volume: 273, Issue:3

    Topics: Aged; Algorithms; Automation; Biopsy, Needle; Contrast Media; Humans; Magnetic Resonance Imaging, Interventional; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Rectum; Time Factors

2014
Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images.
    Journal of magnetic resonance imaging : JMRI, 2015, Volume: 42, Issue:2

    Topics: Blood Flow Velocity; Computer Simulation; Contrast Media; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Models, Biological; Models, Statistical; Neovascularization, Pathologic; Organometallic Compounds; Principal Component Analysis; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity

2015
Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy.
    European journal of radiology, 2016, Volume: 85, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Digital Rectal Examination; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Meglumine; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organometallic Compounds; Patient Care Planning; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment

2016
Magnetic resonance-guided biopsy of the prostate: feasibility, technique, and clinical applications.
    Topics in magnetic resonance imaging : TMRI, 2008, Volume: 19, Issue:6

    Topics: Aged; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging, Interventional; Male; Meglumine; Organometallic Compounds; Prostate; Prostatic Neoplasms

2008
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.
    Investigative radiology, 2010, Volume: 45, Issue:3

    Topics: Aged; Aged, 80 and over; Biopsy; Contrast Media; Feasibility Studies; Humans; Magnetic Resonance Imaging, Interventional; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Prostatic Neoplasms

2010
MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
    European journal of radiology, 2010, Volume: 76, Issue:3

    Topics: Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans; Image Enhancement; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meglumine; Models, Biological; Organometallic Compounds; Prostate; Prostatic Neoplasms

2010
Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies.
    European radiology, 2010, Volume: 20, Issue:12

    Topics: Aged; Biomarkers, Tumor; Biopsy, Needle; Diffusion Magnetic Resonance Imaging; Humans; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Interventional

2010
Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US.
    Radiology, 2011, Volume: 259, Issue:2

    Topics: Aged; Biopsy; Contrast Media; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Phospholipids; Prostatic Neoplasms; Retreatment; Sulfur Hexafluoride; Treatment Outcome; Ultrasonography, Interventional; Ultrasound, High-Intensity Focused, Transrectal

2011
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
    Urologic oncology, 2013, Volume: 31, Issue:6

    Topics: Aged; Biopsy; Cohort Studies; Contrast Media; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Multimodal Imaging; Neoplasm Grading; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity

2013
Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy.
    AJR. American journal of roentgenology, 2011, Volume: 197, Issue:4

    Topics: Aged; Biopsy; Contrast Media; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Radiosurgery; Robotics; Statistics, Nonparametric; Treatment Outcome

2011
Preoperative detection and localization of accessory pudendal artery with contrast-enhanced MR angiography.
    Radiology, 2012, Volume: 262, Issue:3

    Topics: Aged; Arteries; Contrast Media; Humans; Image Interpretation, Computer-Assisted; Laparoscopy; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Prostate; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Treatment Outcome

2012
T2-weighted hypointense lesions within prostate gland: differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging--hystopatology correlations.
    European journal of radiology, 2012, Volume: 81, Issue:11

    Topics: Aged; Contrast Media; Diagnosis, Differential; Humans; Italy; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic

2012
Dynamic contrast-enhanced MR evaluation of prostate cancer before and after endorectal high-intensity focused ultrasound.
    La Radiologia medica, 2013, Volume: 118, Issue:5

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Contrast Media; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Treatment Outcome; Ultrasound, High-Intensity Focused, Transrectal

2013
Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
    La Radiologia medica, 2008, Volume: 113, Issue:5

    Topics: Aged; Choline; Citric Acid; Contrast Media; Creatine; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostate; Prostatic Neoplasms; Whole Body Imaging

2008
MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens.
    Radiology, 1994, Volume: 190, Issue:2

    Topics: Aged; Contrast Media; Drug Combinations; False Negative Reactions; False Positive Reactions; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Prospective Studies; Prostatic Neoplasms; Retrospective Studies

1994
Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging.
    Radiology, 1993, Volume: 186, Issue:1

    Topics: Aged; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prostate; Prostatic Neoplasms

1993
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
    Radiology, 1997, Volume: 203, Issue:3

    Topics: Aged; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Observer Variation; Organometallic Compounds; Pentetic Acid; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique

1997